Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Mallinckrodt
McKesson
AstraZeneca
Harvard Business School

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drug Price Trends for MEGESTROL ACET

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for MEGESTROL ACET

Average Pharmacy Cost for MEGESTROL ACET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MEGESTROL ACET 40 MG/ML SUSP 00054-3542-58 0.08856 ML 2019-10-23
MEGESTROL ACET 40 MG/ML SUSP 49884-0907-61 0.09115 ML 2019-10-23
MEGESTROL ACET 40 MG/ML SUSP 50383-0859-24 0.08856 ML 2019-10-23
MEGESTROL ACET 40 MG/ML SUSP 49884-0907-38 0.08856 ML 2019-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for MEGESTROL ACET

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
MEGESTROL ACETATE 40MG TAB 10X10 Major Pharmaceuticals 00904-3571-61 100UD 16.42 0.16420 EACH 2018-12-01 - 2023-11-30 FSS
MEGACE 40MG/ML ORAL SUSP Bristol-Myers Squibb Company 00015-0508-42 240ML 112.61 0.46921 ML 2018-05-01 - 2023-04-30 Big4
MEGACE 40MG/ML ORAL SUSP Bristol-Myers Squibb Company 00015-0508-42 240ML 151.21 0.63004 ML 2018-05-01 - 2023-04-30 FSS
MEGACE 40MG/ML ORAL SUSP Bristol-Myers Squibb Company 00015-0508-42 240ML 115.18 0.47992 ML 2019-01-01 - 2023-04-30 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Mallinckrodt
Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.